About 20% of all deaths in the United Kingdom are due to lung disease. 1 The common causes are lung cancer, pneumonia, and chronic obstructive pulmonary disease (COPD). Services for those with lung cancer are well developed and configured such that palliative care is an integral part of management from diagnosis until death. Other respiratory conditions, such as diffuse parenchymal lung disease (DPLD) (for example, fibrosing alveolitis), may have 2 to 5 year survival figures as poor as those for lung cancer. 2 Mortality is similarly high among those with severe COPD. [3] [4] [5] One study showed that 2 years after an acute admission because of an exacerbation of COPD, mortality is 49%, and that 50% of those who have required assisted ventilation are likely to have died within 1 year of that episode. Previously published studies have suggested that communication with these patients is often sub-optimal and discussions regarding end of life decisions are rarely instituted with either patients or patients' relatives. [6] [7] [8] In addition to these potential deficiencies in communication, these patients also receive less palliative care support from either district nurses or specialist palliative care nurses. 7, 9, 10 The National Council for Palliative Care has been working to ensure that all of those who require palliative care can access it regardless of diagnosis or setting of care and this led to the formation of the Chronic Respiratory Disease Policy Group (www.ncpc.org.uk/policy_unit/circ_resp_pg. html). It became apparent that the extent to which specialist palliative care services are available for those with nonmalignant lung disease in England, Wales, and Northern Ireland remains unclear and for this reason the National Council for Palliative Care and the British Thoracic Society (BTS) undertook this survey of respiratory physicians.
Methods
The aims of this survey were to elucidate availability and access to specialist palliative care services (for in-patient, out-patient, and day care settings), to identify whether noninvasive ventilation was available within specialist palliative care services, to determine the existence or otherwise of formal policies for those with chronic lung disease nearing the end of life, and to seek respiratory physicians' views regarding specialist palliative care services to which they would wish their patients to have access. The questionnaire used was adapted from a longer questionnaire to be used by the National Council for Palliative Care among specialist palliative care consultants and was limited to 11 questions. The questionnaire was sent to 210 named respiratory physicians each representing a major hospital in England, Wales, and Northern Ireland. These physicians were selected from the BTS database as being the lead person in that hospital for BTS surveys. The recipient was requested to pass the questionnaire on to another respiratory colleague if they felt that colleague was more appropriately equipped to complete the survey. The forms were returned anonymously and neither respondent nor hospital could be identified.
Results
In all, 107 replies were received from respiratory physicians working in 104 major hospitals in England, Wales, and Northern Ireland; the response rate was 51.0%. All respondents reported that they and their departments and service cared for those with COPD and end-stage DPLD and all but three respondents also cared for those with asbestosis. About 89 respondents (85.0%) cared for those with respiratory failure secondary to chest wall deformity and respiratory muscle weakness, and 35 (32.7%) respondents included care for adults with cystic fibrosis. Physicians were supported by a mean of 3.4 respiratory nurse specialists per department, and 79 (73.8%) respondents had a specialist lung cancer nurse attached to their service (a mean of 1.3 whole-time equivalent persons per department). However, only 16 physicians (20.3%) reported that the lung cancer nurse also cared for those with nonmalignant lung disease. Table 1 shows the ease of access respiratory physicians reported for their patients with severe nonmalignant chronic lung disease to hospice in-patient care, day care, and outpatient care, and the ease with which they could obtain a palliative care consultation for in-patients and ease of access to community palliative care (for both nursing needs, provision of aids, and nutritional assessment and support). Consultations with palliative medicine physicians were easily available for 66% of respondents for their in-patients and 40% reported easy access to a palliative medicine specialist out-patient consultation service. Spontaneous free-text comments were made by respondents to the effect that access for those with respiratory muscle weakness due to motor neurone disease was often excellent, but access for those with COPD and particularly for those with pulmonary fibrosis was poor. About 23 (21.5%) respondents reported that they had referred to a specialist palliative care unit, patients who required in-patient noninvasive ventilation, and an almost similar percentage (19.6%) have referred to a specialist palliative care unit patients who needed noninvasive ventilation in their own home. Those who reported that they had Only 23 respondents (21.5%) reported having formal policies or procedures in place in their departments for patients with chronic respiratory disease nearing the end of life, and the departments where these policies were in place 22 of 23 positive responses (95.7%) reported that these policies had been developed in conjunction with specialist palliative care colleagues. In all, 94 of 107 respondents (87.9%) said that they did not have a formal process for initiating end of life care discussions and only 21 (22.3%) respondents said that they were in the process of developing these policies.
With regards to end of life decision making, no respondent thought that it was appropriate to initiate this at the time of diagnosis. About 29 (27.9%) respondents thought that an admission for an exacerbation was an appropriate indicator of need for end of life discussion, whereas a further 59 respondents (55.1%) suggested that the appropriate time was after a first episode of noninvasive ventilatory support. A total of 21 (19.6%) respondents reported other suggested times when end of life decision making should be undertaken and these included when caring for those having very frequent repeated exacerbations or those with very poor function/quality of life (five respondents, 4.7%) or when obviously "end stage"/very severe (eight respondents, 7.5%). About 18 respondents (16.8%) not unreasonably said that it was impossible to generalize and that the optimal time depended upon the individual patients and when they are ready for such discussions. Over half of all respondents (n = 56, 52.3%) said that the carers of their patients with chronic lung disease did not have access to bereavement counseling. When respiratory physicians were asked why they would look for assistance from a specialist palliative care service, their responses were (multiple responses possible) as follows: for symptom management (n = 67, 62.6%), psychological support (n = 75, 70.1%), management of end of life (n = 67, 62.6%), and bereavement support (n = 59, 55.1%). Smaller numbers reported that they would wish to access specialist palliative care services for provision of aids and equipment (n = 23, 21.5%), social (n = 28, 26.2%), and spiritual support (n = 31, 29.0%). However, practical coordination of support services was mentioned as a need by 50 (46.7%), as was advanced care planning by 47 (43.9%). A summative final question ("Do you perceive gaps in the current specialist palliative care services in your locality for patients with chronic obstructive respiratory disease?") elucidated the response that 87 of 107 respiratory physicians (81.3%) perceived gaps in the current specialist palliative care services in their locality for patients with severe chronic nonmalignant lung disease.
Discussion
Any questionnaire survey has limitations and in this survey there was a 51% response rate. Although the lead person in each hospital was surveyed, we had no way of assessing the representativeness or indeed accuracy of their responses. Furthermore, it was not always clear whether respondents had attempted to access a service and found it to be not available or whether their response reflected their perception of availability. Nevertheless, the survey does suggest that access and liaison are not as well developed or as universal as they are for those, for example, with lung cancer.
Although specialist palliative care advice was easily obtainable for two-thirds of hospital inpatients, there was perceived to be less easy access to palliative medicine out-patient services and only a minority of chest physicians reported easy access to hospice in-patient or day care for their patients with nonmalignant lung disease.
The diseases suffered by the patients being managed by these respiratory physicians will be diverse. However, the largest numerical proportion is likely to be those with COPD and this disease is a major cause of mortality. [3] [4] [5] Many of these patients now receive noninvasive ventilatory (NIV) support for the treatment of acidosis associated with respiratory failure at the time of exacerbations. The initiation of NIV is an indicator of the severity of disease, and one-half of these patients would have died within 1 year of use of assisted ventilation. These patients sometimes express distress at use of this intervention which is likely to be toward the end of life. This survey reveals that in only a minority of services had provision been made for these patients to discuss how they wish to be cared for during their next exacerbation. Previous surveys 11 have similarly suggested a variable perception as to the optimal timing for such discussions but have suggested that where undertaken they occur very late in the course of the disease. Informal discussion with colleagues, most of whom are well used to this sort of discussion with their patients with lung cancer, suggests that this lack of communication may reflect less certainty regarding the downhill course of this disease compared with lung cancer. Spirometry alone is a poor predictor of mortality and new indices, such as the BODE (BMI, obstruction (FEV 1 ), dyspnea, exercise tolerance) index, have been promoted. 12 Initial work suggests that the BODE index is better than the forced expiratory volume in one second (FEV 1 ) at predicting the risk of death among patients with COPD but even this is an imprecise predictive tool in individuals. 13 As published studies of those with COPD and fibrosing alveolitis would suggest that for many the prognosis is as poor and as predictable as for those with lung cancer, another determinant of when an end of life discussion was needed might be obtained by wider use of the "surprise question": "Would you be surprised if the patient died in the next 12 months?" (recommended in the subsequently published End of Life Strategy for England). 13 Our survey concludes that most respondents felt that as a minimum an episode of assisted ventilation should trigger such consideration. This should probably take place subsequently during follow-up in a clinic with an extended consultation time. 14 For many patients, this discussion may lead to agreement that although noninvasive ventilation may be used during a subsequent exacerbation, if this failed to correct the situation, progression to intubation and mechanical ventilation would not be undertaken. This then leads to consideration as to whether an acute hospital bed, often on a High Dependency or Medical Respiratory Unit, is the most appropriate place for a patient receiving what is a essentially a palliative intervention and whether such NIV should alternatively be as available in specialist palliative care services as is a syringe driver for the relief of pain. The potential size of the demand for such a service is unclear. In our survey, about a fifth of chest physicians reported that they had referred to a specialist palliative care service for patients who needed NIV in an in-patient unit and those who needed NIV in their own home. The survey did not distinguish or relate these responses to the disease necessitating ventilation, and it is perhaps more likely that these were patients requiring ventilatory support because of neuromuscular diseases or chest wall deformities rather than those with COPD. It may indeed be easier for specialist palliative care services to offer continued nasal ventilation to those with neuromuscular disorder (where the patient would have been used to the intervention) than it would be to provide such support temporarily to those in the terminal phases of COPD and ventilatory failure where the patient may have only received mask ventilation once or twice before, over a short period of time. If NIV does need to be made more available within specialist palliative care services, there might clearly be resource implications but also a need for appropriate training if staff are to feel confident with this intervention. Ideally, this would involve close work between respiratory and palliative care services and might be an issue which could be addressed during the planning of a joint local end of life strategy. Some patients may choose to die at home (with or without NIV). Currently, however, we have the paradox of an increasing number expressing a desire to die at home but the numbers actually doing so decreasing. 15 This has a significant impact on community services, including community palliative care for those with nonmalignant respiratory disease and careful local planning will be required to meet these needs.
The majority of physicians reported that they had a formal end of life care policy and had developed these in conjunction with their local specialist palliative care services. This suggests that collaborative working has already begun and can be beneficial, so it should be encouraged locally. Each local health and social care community needs to develop an end of life care strategy for people with both respiratory and palliative care services working together. The American Thoracic Society Clinical Policy statement on palliative care for patients with respiratory diseases represents a good starting point for discussion of this issue. 16 The aim should be to ensure that the same quality of service is available for those with severe, advanced nonmalignant lung disease as is currently available for those with lung cancer.
